Evaluation of the Effects of Biological Therapy with Infliximab in an Experimental Model of Diversion Colitis

J Gastrointest Surg. 2021 Oct;25(10):2681-2683. doi: 10.1007/s11605-021-04981-8. Epub 2021 Mar 22.
No abstract available

Keywords: Colitis; Immunohistochemistry; Infliximab; Rats; Tumor Necrosis Factor-alpha.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Therapy
  • Colitis* / chemically induced
  • Colitis, Ulcerative* / drug therapy
  • Humans
  • Infliximab
  • Models, Theoretical
  • Tumor Necrosis Factor-alpha

Substances

  • Tumor Necrosis Factor-alpha
  • Infliximab